MEMPHIS, Tenn. — The world’s larged COVID-19 vaccine study began Monday, with the first of 30,000 volunteers helping to test shots created by the U.S. government, according to the Associated Press.
The experimental vaccine was developed by the National Institutes of Health and Moderna Inc.
Volunteers won’t know if they’re getting the real shot or a dummy version, according to the AP report.
After two doses, scientists will track which group experiences more infections as they go about their daily lives, especially in areas where the virus is rapidly spreading.
Moderna said the vaccination was done in Savannah, Georgia, the first site to get underway among more than seven dozen trial sites scattered around the country, according to the report.
Vaccine testing isn’t just to see if the shots will work; they’re needed to check if each potential vaccine is safe.
Next month, the final study of the Oxford shot begins, followed by Johnson & Johnson in September and Novavax in October.
Pfizer Inc. plans its own 30,000-person study this summer, according to the report.
Recently, more than 150,000 Americans filled out an online registry expressing interest in volunteering for vaccine testing.
© 2020 Cox Media Group